Wed.Mar 15, 2023

article thumbnail

With focus on fibrosis, startup Mediar draws big pharma backing

Bio Pharma Dive

Novartis joined venture investor Sofinnova in leading an $85 million investment in the startup that also involved Pfizer, Eli Lilly and Bristol Myers Squibb

307
307
article thumbnail

HSBC acquires SVB UK in strategic move to expand presence in biotech sector

Pharmaceutical Technology

The multinational bank HSBC’s acquisition of Silicon Valley Bank UK was praised as the UK Government and Bank of England moved quickly to secure the deal over the weekend.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Jounce gets rival takeover bid from company controlled by shareholder

Bio Pharma Dive

Tang Capital’s Concentra Biosciences is offering Jounce investors a competing bid to the biotech’s planned reverse merger with Redx Pharma

300
300
article thumbnail

Novo Nordisk to reduce US list prices of insulin products

Pharmaceutical Technology

Novo Nordisk has announced plans to reduce the US wholesale acquisition cost (WAC), also known as the list price, of several pre-filled insulin pens and vials by up to 75% for people living with type 1 and type 2 diabetes.

Insulin 147
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.

article thumbnail

US names first drugs to face price hike penalty

Bio Pharma Dive

Under the Inflation Reduction Act, pharma companies owe rebates to Medicare for price increases that exceed inflation. But they won’t need to pay until 2025

article thumbnail

AcelRx Pharmaceuticals to sell drug DSUVIA to Alora

Pharmaceutical Technology

AcelRx Pharmaceuticals has announced the sale of its drug DSUVIA (sufentanil sublingual tablet) to Alora Pharmaceuticals.

Sales 147

More Trending

article thumbnail

Owlstone Medical collaborates with Bicycle Therapeutics

Pharma Times

Duo team up for the development of antigen-targeted probes for early cancer detection

article thumbnail

Parker Review publishes FTSE 350 firms’ ethnic diversity targets in the UK

Pharmaceutical Technology

The Parker Review committee has announced new targets for improving the ethnic diversity of FTSE 350 senior management teams and large private businesses in the UK, which include pharma companies.

article thumbnail

PBD Biotech reveals vital update to TB test

Pharma Times

Lyophilized PCR reaction bead reduces the cost of transport and extends shelf life for the test

125
125
article thumbnail

Pfizer adjusts EU vaccine deal but still wants payment for undelivered doses: FT

Fierce Pharma

Pfizer adjusts EU vaccine deal but still wants payment for undelivered doses: FT esagonowsky Wed, 03/15/2023 - 08:43

article thumbnail

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

article thumbnail

Non-Stimulant ADHD Drugs: Qelbree Versus Strattera

XTalks

Attention-deficit/hyperactivity disorder (ADHD) is among the most common childhood neurobehavioral mental health disorders.

Drugs 97
article thumbnail

In his first year as Johnson & Johnson CEO, Duato scored $13.1M payout

Fierce Pharma

In his first year as Johnson & Johnson CEO, Duato scored $13.1M payout aliu Wed, 03/15/2023 - 10:09

97
article thumbnail

FDA to Require Breast Density Notification Amongst Other Updates to Mammography Regulations

FDA Law Blog

By Véronique Li, Senior Medical Device Regulation Expert — Earlier this month, FDA published a final rule to update the mammography regulations, issued under the Mammography Quality Standards Act of 1992 (MQSA) and the Federal Food, Drug, and Cosmetic Act (FD&C Act).

article thumbnail

AbbVie's Humira, 5 Pfizer drugs among those with price hikes that exceeded inflation rate

Fierce Pharma

AbbVie's Humira, 5 Pfizer drugs among those with price hikes that exceeded inflation rate kdunleavy Wed, 03/15/2023 - 10:09

Drugs 97
article thumbnail

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

article thumbnail

Immuno-Oncology Pipeline Cuts Explained

BioSpace

Immuno-Oncology Pipeline Cuts Explained 3/16/2023

82
article thumbnail

Amgen sued by investors for failing to disclose $10.7B tax bill

Fierce Pharma

Amgen sued by investors for failing to disclose $10.7B tax bill zbecker Wed, 03/15/2023 - 11:32

87
article thumbnail

Seamless Launches with $12.5M for Programmable Recombinases Platform

BioSpace

Seamless Launches with $12.5M for Programmable Recombinases Platform 3/16/2023

80
article thumbnail

Interview with Neuromod COO Diarmuid Flavin About the FDA Approval of Tinnitus Treatment Lenire – Xtalks Life Science Podcast Ep. 101

XTalks

Diarmuid Flavin Chief Operating Officer Neuromod Devices This episode features an interview with Diarmuid Flavin, Chief Operating Officer (COO) of Neuromod, a Dublin-based medical device company specializing in the treatment of tinnitus, a condition known as “ringing in the ears.”

article thumbnail

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

article thumbnail

Aldena Raises $30M to Advance Skin-Deep siRNA Therapies

BioSpace

Aldena Raises $30M to Advance Skin-Deep siRNA Therapies 3/16/2023

77
article thumbnail

New public Clinical Trials database leads to increased tax & regulatory transparency – risk of supply chain disruption / recall

Pharma Business Blog

Dears Please find hereinafter the latest news related to Clinical Trials in the EU with a respective indirect tax and pharma regulatory licensing impact: 1.

article thumbnail

Is Job Hopping an Effective Career Advancement Strategy?

BioSpace

Is Job Hopping an Effective Career Advancement Strategy? 3/16/2023

76
article thumbnail

Novel Cell Cytometers: Need of the Hour

Roots Analysis

The domain of novel cell cytometers has attracted much attention of within the global biopharmaceutical industry in recent years. This popularity can be attributed mainly to the need of these tools to address the rising prevalence of chronic disease conditions.

article thumbnail

NABP Hopes to Fill a Key Gap in DSCSA Compliance: Local Pharmacies

Pharmaceutical Commerce

The Pulse online service will provide free resources to enable pharmacy to meet drug traceability rules.

article thumbnail

Using Digital Print to Create Stellar Clinical Trial Materials: A Behind-the-Scenes Look

Imperical Blog

Imperial’s digital presses support the front lines of clinical research across the globe. All the clinical trial print materials we produce for you—for example, ISF and pharmacy binders, patient recruitment materials, investigator meeting materials, and dosing diaries—are produced in the U.S.

article thumbnail

Ricardo Carvajal to Moderate Panel at FDLI’s Food and Dietary Supplement Safety and Regulation Conference

FDA Law Blog

Hyman, Phelps & McNamara, P.C.’s s Ricardo Carvajal will be moderating a panel on “The Use of Bioactive Substances in Food and Dietary Supplements” during the Food and Drug Law Institute (FDLI) Food and Dietary Supplement Safety and Regulation Conference. The conference will be held live in Washington DC on March 23-24, but virtual registration is an option.

article thumbnail

In fresh threat to Incyte's Opzelura, Dermavant's Vtama cream hits goal in eczema phase 3 study

Fierce Pharma

In fresh threat to Incyte's Opzelura, Dermavant's Vtama cream hits goal in eczema phase 3 study esagonowsky Wed, 03/15/2023 - 10:56

59
article thumbnail

Five cities recognized for public health achievements at Partnership for Healthy Cities Summit

The Pharma Data

artnership for Healthy Cities award recipients include Montevideo, Uruguay for food policy; Mexico City, Mexico for road safety; Vancouver, Canada for surveillance; Athens, Greece for overdose prevention, and Bengaluru, India for tobacco control. The first-of-its-kind Summit was convened in London by Bloomberg Philanthropies, World Health Organization, Vital Strategies, and Mayor Sadiq Khan of London.

article thumbnail

Building a Community of Trust in Epilepsy & Rare Syndromes

Fierce Pharma

Building a Community of Trust in Epilepsy & Rare Syndromes jpiatt Wed, 03/15/2023 - 15:38

52
article thumbnail

Pfizer and BioNTech Receive U.S. Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Booster in Children Under 5 Years

The Pharma Data

Pfizer Inc. NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) to provide a single booster dose of the companies’ Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine in children 6 months through 4 years of age (also referred to as under 5 years of age) at least 2 months after completion of primary vaccination with three doses of the Pfizer-BioNTech COVID-19 Original Vaccine.

article thumbnail

Global 'Cancer Grand Challenges' initiative outlines nine toughest challenges to tackling the disease

BioPharma Reporter

A research initiative co-led by Cancer Research UK and the National Cancer Institute announces funding to tackle core challenges in cancer treatment. Bio Developments

article thumbnail

Bristol Myers Squibb Announces Progress Toward Long-Term Inclusion & Diversity Goals and Health Equity Commitments

The Pharma Data

Commitments demonstrate leadership in advancing health equity and workforce representation to better serve patients and communities – $10 million in 2023 grant funding to 17 U.S.

article thumbnail

New patent for Radius Health drug TYMLOS

Drug Patent Watch

Annual Drug Patent Expirations for TYMLOS Tymlos is a drug marketed by Radius Health Inc and is included in one NDA. It is available from one supplier. There are five… The post New patent for Radius Health drug TYMLOS appeared first on DrugPatentWatch - Make Better Decisions. Patent Added

article thumbnail

Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Published in Nature

The Pharma Data